Finance

Lists
NRXP:NASDAQ
NRX Pharmaceuticals Inc
2,85 US$
0,00%
(0,00) 1D
2,85 US$
0,00% (0,00)
After hours
Closed: 12 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRXP...
Open
2,85 US$
High
2,93 US$
Low
2,81 US$
Mkt. cap
123,39 მლნ.
Avg. vol.
621,64 ათ.
Volume
479,13 ათ.
52-wk high
5,06 US$
52-wk low
1,62 US$
EPS
-0,74 US$
Beta
2,08
Shares outstanding
43,30 მლნ.
No. of employees
29
Open
2,85 US$
High
2,93 US$
Low
2,81 US$
Mkt. cap
123,39 მლნ.
Avg. vol.
621,64 ათ.
Volume
479,13 ათ.
52-wk high
5,06 US$
52-wk low
1,62 US$
EPS
-0,74 US$
Beta
2,08
Shares outstanding
43,30 მლნ.
No. of employees
29
News stories
From web sources and news partners
About NRX Pharmaceuticals Inc
CEO-
Employees29
Founded2015
Headquartersუილმინგტონი, დელავერის შტატი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Analyst ratings
Based on 3 analysts giving stock ratings to NRXP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NRXP in the last 3 months.
Highest
Current 2,85 US$
50,00 US$ (+1 654,39%)
Average
35,00 US$ (+1 128,07%)
Lowest
10,00 US$ (+250,88%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
50,00 US$
+1 654,4%
09/30/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
45,00 US$
+1 478,9%
09/21/2026
Thomas Shrader
BTIG
Buy
Maintained
10,00 US$
+250,9%
09/14/2026
Elemer Piros
Lucid Capital
Buy
Initiated
49,00 US$
+1 619,3%
05/13/2026
Jason Kolbert
D. Boral Capital
Buy
Maintained
34,00 US$
+1 093%
04/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
242,00 ათ.
983,00 ათ.
1,07 მლნ.
1,10 მლნ.
Cost of goods sold
97,00 ათ.
408,00 ათ.
631,00 ათ.
675,00 ათ.
Cost of revenue
97,00 ათ.
408,00 ათ.
631,00 ათ.
675,00 ათ.
Research and development expenses
1,43 მლნ.
558,00 ათ.
1,31 მლნ.
2,12 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,81 მლნ.
4,57 მლნ.
3,81 მლნ.
4,74 მლნ.
Operating expense
4,26 მლნ.
5,17 მლნ.
5,18 მლნ.
6,93 მლნ.
Total operating expenses
4,36 მლნ.
5,58 მლნ.
5,82 მლნ.
7,60 მლნ.
Operating income
-4,12 მლნ.
-4,59 მლნ.
-4,75 მლნ.
-6,50 მლნ.
Other non operating income
-366,00 ათ.
1,59 მლნ.
3,54 მლნ.
-9,78 მლნ.
EBT including unusual items
-5,89 მლნ.
360,00 ათ.
-1,43 მლნ.
-16,52 მლნ.
EBT excluding unusual items
-4,48 მლნ.
-3,67 მლნ.
-1,44 მლნ.
-16,52 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5,89 მლნ.
360,00 ათ.
-1,43 მლნ.
-16,52 მლნ.
Net profit margin
-2 433,88%
36,62%
-133,90%
-1 500,45%
Earnings per share
-0,51
0,18
-0,04
-0,24
Interest and investment income
2,00 ათ.
4,00 ათ.
5,00 ათ.
6,00 ათ.
Interest expense
-
-671,00 ათ.
-233,00 ათ.
-240,00 ათ.
Net interest expenses
2,00 ათ.
-667,00 ათ.
-228,00 ათ.
-234,00 ათ.
Depreciation and amortization charges
26,00 ათ.
42,00 ათ.
63,00 ათ.
66,00 ათ.
EBITDA
-4,11 მლნ.
-4,55 მლნ.
-4,68 მლნ.
-6,43 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები